DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

March 10, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Coronary Artery Disease
Interventions
DEVICE

DynamX Novolimus-eluting Coronary Bioadaptor System

All patients will receive at least one DynamX Bioadaptor implant in a commercial setting in accordance with the product's Instructions for Use

Trial Locations (17)

Unknown

RECRUITING

University Hospital St. Pölten, Pölten

RECRUITING

Curaçao Medical Center, Willemstad

RECRUITING

Heartology Cardiovascular Hospital, Jakarta

RECRUITING

Jakarta Heart Center, Jakarta

RECRUITING

Medistra Hospital, Jakarta

RECRUITING

Siloam Hospitals, Jakarta

RECRUITING

Centro Cardiologico Monzino, Milan

RECRUITING

"Azienda Ospedaliera Universitaria Federico II", Napoli

RECRUITING

Policlinico Tor Vergata, Rome

RECRUITING

Jordon Hospital, Amman

RECRUITING

The Specialty Hospital, Amman

RECRUITING

King Fahad Armed Forces Hospital, Jeddah

RECRUITING

Istanbul Medipol Mega University Hospital, Istanbul

RECRUITING

Memorial Bahçelievler Hospital, Istanbul

RECRUITING

Al Qassimi Hospital, Sharjah city

RECRUITING

Tam Duc Heart Hospital, Ho Chi Minh City

RECRUITING

Kiến Giang General Hospital, Kiến Giang

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT06074549 - DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System | Biotech Hunter | Biotech Hunter